 Smith Nephew PLC LSE:SN reported a 4.8 increase in underlying revenue for the third quarter and forecast revenue growth for the full year in the middle of its previously guided range of 4-5. The medical products company left its trading profit margin guidance for the year unchanged at around 17.5, down from 18 in 2021. 